More than ever, drug makers need to be fleet and flexible-and they need their software to be the same.
Jay DiMare
Advertisement
Jay DiMare is an associate partner at IBM Global Business Services.
Articles by Jay DiMare
Advertisement
Latest Updated Articles
The New Biopharmaceutical Blueprint: Service-Oriented Architecture in ManufacturingPublished: November 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
AAPS PharmSci 360 2025: Trends in Bioanalysis
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
